Articles

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, The Netherlands
Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, The Netherlands
Department of Internal Medicine, Universitätsklinikum “Carl-Gustav-Carus”, Dresden, Germany
Department of Haematology, University Hospitals NHS Foundation Trust, Bristol, UK
First Medical Department, Elisabethinen Hospital, Linz, Austria
Servicio Central de Citometría (NUCLEUS) and Department of Medicine, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer, (CSIC/USAL and IBSAL), Universidad de Salamanca, Spain
Servicio Central de Citometría (NUCLEUS) and Department of Medicine, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer, (CSIC/USAL and IBSAL), Universidad de Salamanca, Spain
Isala Clinics, Zwolle, The Netherlands
HematoLogics, Inc., Seattle, WA, USA
HematoLogics, Inc., Seattle, WA, USA
HematoLogics, Inc., Seattle, WA, USA
Department of Hematology, Hospital Universitario de Guadalajara, Spain
HMDS, St. James’s University Hospital, Leeds, UK
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Department of Laboratory Medicine – Laboratory for Hematology, Radboud University Medical Center, Nijmegen, The Netherlands
Department of Hematology and Oncology, Buddhist Tzu Chi General Hospital, Tzu Chi University, Hualien, Taiwan
Laboratoire d’Hématologie, CHU Dupuytren, Limoges, France
Laboratoire d’Hématologie, CHU Dupuytren, Limoges, France
Department of Immunology-Histocompatibility, Evangelismos Hospital, Athens, Greece
Department of Pathobiology and Laboratory Medicine, University of Toronto, University Health Network, Toronto General Hospital, ON, Canada;Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
King’s College Hospital, London, UK
King’s College Hospital, London, UK
Laboratoire d’Hématologie, CHU de Nantes, France
Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Italy
MLL Munich Leukemia Laboratory, Germany
Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, The Netherlands
Vol. 102 No. 2 (2017): February, 2017 https://doi.org/10.3324/haematol.2016.147835